Anti-IL12/23IL-12/23JAK inhibitorsanti-TNFCrohn’s Disease
…50%). However, 79% required a 3rd line agent, most of which was Anti-IL12/23 (50%). 29% required a 4th line agent and 10% were on a 5th line…
2articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: IL-12/23 ×
IL-12/23
This drug is selected. Its supporting articles are shown below.
Articles mentioning IL-12/23
2 articles · page 1 of 185.3%
JAK inhibitorIL-12/23anti-IL-12/23anti-TNFulcerative colitisrheumatoid arthritispolymyalgia rheumaticaileocolonic diseaseInflammatory bowel diseaseGRC+3 more
…s switches were anti-TNF to anti-IL-12/23 (n=5) and IL-12/23 to JAK inhibitor (n=4). Non-medication-related actions (e.g. investigations or r…